Navigation Links
OPTIMIZERx Corporation Announces the Resignation of the Company's Current CEO & Chairman Mr. Shadron L. Stastney
Date:9/20/2013

ROCHESTER, Mich., Sept. 20, 2013 /PRNewswire/ -- OPTIMIZERx Corp. (OTCQB: OPRX) today announced that the Company's current Chief Executive Officer, Mr. Shadron L. Stastney, has provided the Board of Directors his resignation for personal reasons. While the Company's Board of Directors has accepted his resignation, effective today, the Company will retain Mr. Stastney's services on a limited basis for advisory work through the end of the year to help the transition with several ongoing projects.

(Logo: http://photos.prnewswire.com/prnh/20130913/DE79474LOGO-a )

The Companies Co-Chairman and founder Mr. David Harrell added, "We appreciate all the valuable contributions made by Mr. Stastney, and we wish him the best of luck in his future endeavors."

Mr. Harrell also stated, "The Company has initiated a search for an executive with proven leadership qualities and experience in the pharmaceutical industry.

Mr. Harrell added, "I will reassume as Chairman of the Board, and we are also considering adding additional staff as our business continues to grow and diversify into additional services such as our OptimizEHR™ strategic planning service that we recently rolled out to help pharmaceutical manufacturers to develop robust brand based digital offerings for the burgeoning Electronic Health Care Records (EHR), software industry."

About OPTIMIZERx Corp : OPTIMIZERx Corp. (OTCQB: OPRX) provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their medications. For more information, please go to www.optimizerxcorp.com

'SAFE HARBOR' This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact:
David Lester,
248-651-6568


'/>"/>
SOURCE OPTIMIZERx Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PDR Network and OPTIMIZERx (SampleMD) Announce Partnership to Deliver Patient Financial Support Programs Within EHR Workflow
2. Updated: Harwood Feffer LLP Announces Investigation of Edwards Lifesciences Corporation
3. TREVENTIS Corporation Closes $4.4 Million Financing with Wellcome Trust
4. B. Riley Exclusive Financial Advisor to Mirth Corporation in Connection with its Corporate Sale to Quality Systems, Inc.
5. Gentris Corporation Launches Next Generation Human Transcriptome Array
6. Euclid Systems Corporation signs agreement with Wenzhou Medical University to promote the use of Orthokeratology to control myopia progression
7. Unilife Corporation Announces Financial Results For Fiscal Year 2013 Fourth Quarter
8. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials to be Presented at the 2013 San Antonio Breast Cancer Conference
9. The X-Change Corporation To Announce Corporate Name Change Next Week; New Industry-Driven Branding to Commence For Global Activities, Services, Product Lines, and Website
10. Unilife Corporation To Announce Financial Results For Fiscal Year 2013 Fourth Quarter And Year End On Tuesday, September 10, 2013
11. Arrayit Corporation Holds Successful Meeting with DHK Medical Products CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):